Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy

被引:447
作者
Minetti, C
Sotgia, F
Bruno, C
Scartezzini, P
Broda, P
Bado, M
Masetti, E
Mazzocco, M
Egeo, A
Donati, MA
Volonté, D
Galbiati, F
Cordone, G
Bricarelli, FD
Lisanti, MP
Zara, F
机构
[1] Univ Genoa, Ist Giannina Gaslini, Serv Malattie Neuromuscolari, I-16147 Genoa, Italy
[2] EO Osped Galliera, Lab Genet Umana, Genoa, Italy
[3] Columbia Univ, Dept Neurol, New York, NY USA
[4] EO Osped Galliera, Div Neonatol, Genoa, Italy
[5] Univ Florence, Dipartimento Pediat, Florence, Italy
[6] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA
关键词
D O I
10.1038/ng0498-365
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Limb-girdle muscular dystrophy (LGMD) is a clinically and genetically heterogeneous group of myopathies. including autosomal dominant and recessive forms(1-3). To date, two autosomal dominant forms have been recognized(2,3): LGMD1A, linked to chromosome 5q, and LGMD1B, associated with cardiac defects and linked to chromosome 1q11-21. Here we describe eight patients from two different families with a new form of autosomal dominant LGMD, which we propose to call LGMD1C, associated with a severe deficiency of caveolin-3 in muscle fibres. Caveolin-3 (or M-caveolin) is the muscle-specific form of the caveolin protein family, which also includes caveolin-1 and -2 (refs 4-9). Caveolins are the principal protein components of caveolae (50-100 nm invaginations found in most cell types) which represent appendages or sub-compartments of plasma membranes(10,11). We localized the human caveolin-3 gene (CAV3) to chromosome 3p25 and identified two mutations in the gene: a missense mutation in the membrane-spanning region and a micro-deletion in the scaffolding domain. These mutations may interfere with caveolin-3 oligomerization and disrupt caveolae formation at the muscle cell plasma membrane.
引用
收藏
页码:365 / 368
页数:4
相关论文
共 30 条
[2]   Interaction of a receptor tyrosine kinase, EGF-R, with caveolins - Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities [J].
Couet, J ;
Sargiacomo, M ;
Lisanti, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (48) :30429-30438
[3]   Molecular and cellular biology of caveolae - Paradoxes and plasticities [J].
Couet, J ;
Li, SW ;
Okamoto, T ;
Scherer, PE ;
Lisanti, MP .
TRENDS IN CARDIOVASCULAR MEDICINE, 1997, 7 (04) :103-110
[4]   Identification of peptide and protein ligands for the caveolin-scaffolding domain - Implications for the interaction of caveolin with caveolae-associated proteins [J].
Couet, J ;
Li, SW ;
Okamoto, T ;
Ikezu, T ;
Lisanti, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (10) :6525-6533
[5]   MEMBRANE ORGANIZATION OF THE DYSTROPHIN-GLYCOPROTEIN COMPLEX [J].
ERVASTI, JM ;
CAMPBELL, KP .
CELL, 1991, 66 (06) :1121-1131
[6]   Endothelial nitric oxide synthase targeting to caveolae - Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells [J].
Feron, O ;
Belhassen, L ;
Kobzik, L ;
Smith, TW ;
Kelly, RA ;
Michel, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (37) :22810-22814
[7]   Dissecting the interaction between nitric oxide synthase (NOS) and caveolin - Functional significance of the NOS caveolin binding domain in vivo [J].
GarciaCardena, G ;
Martasek, P ;
Masters, BSS ;
Skidd, PM ;
Couet, J ;
Li, SW ;
Lisanti, MP ;
Sessa, WC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (41) :25437-25440
[8]   MUTATIONS IN THE LAMININ ALPHA-2-CHAIN GENE (LAMA2) CAUSE MEROSIN-DEFICIENT CONGENITAL MUSCULAR-DYSTROPHY [J].
HELBLINGLECLERC, A ;
ZHANG, X ;
TOPALOGLU, H ;
CRUAUD, C ;
TESSON, F ;
WEISSENBACH, J ;
TOME, FMS ;
SCHWARTZ, K ;
FARDEAU, M ;
TRYGGVASON, K ;
GUICHENEY, P .
NATURE GENETICS, 1995, 11 (02) :216-218
[9]   DYSTROPHIN - THE PROTEIN PRODUCT OF THE DUCHENNE MUSCULAR-DYSTROPHY LOCUS [J].
HOFFMAN, EP ;
BROWN, RH ;
KUNKEL, LM .
CELL, 1987, 51 (06) :919-928
[10]   EVIDENCE FOR A REGULATED INTERACTION BETWEEN HETEROTRIMERIC G-PROTEINS AND CAVEOLIN [J].
LI, SW ;
OKAMOTO, T ;
CHUN, MY ;
SARGIACOMO, M ;
CASANOVA, JE ;
HANSEN, SH ;
NISHIMOTO, I ;
LISANTI, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (26) :15693-15701